Anokion Competitors and Similar CompaniesClear all
Anokion's competitors and similar companies include Glyphic Biotechnologies, Immunocore, Genevant and Monte Rosa Therapeutics.
 Glyphic Biotechnologies Glyphic Biotechnologies is a biotechnology company that provides proteomics solutions. |  Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. |  Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. |  Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. | ||
Founding Date | Founding Date 2010 | Founding Date 2021 | Founding Date 2008 | Founding Date 2017 | Founding Date 2018 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Ecublens, CH HQ Cambridge, US | Locations Berkeley, US HQ | Locations Milton, GB HQ Conshohocken, US Rockville, US | Locations New York, US HQ | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US |
Employees | Employees 219% decrease | Employees 3310% increase | Employees 493 | Employees 524% decrease | Employees 75 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) 575.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $400m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $123.7m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($35.5m) (FY, 2025) | Net income N/A | Net income ($38.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 40m (over 6 years ago) | Latest funding round $ 6m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 77.6m | Total funding raised $ 6m | Total funding raised $ 565m | Total funding raised N/A | Total funding raised $ 223.5m |
For sources of this data, please see the company profile
View Company Profiles
Glyphic Biotechnologies
HQ
Berkeley, US
Employees
33↑ 10% increase
Glyphic Biotechnologies is a biotechnology company that provides proteomics solutions.
View companyImmunocore
HQ
Milton, GB
Employees
493
Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases.
View companyGenevant
HQ
New York, US
Employees
52↓ 4% decrease
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View companyMonte Rosa Therapeutics
HQ
Boston, US
Employees
75
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company